Automated Insulin Delivery

The AJMC® Automated Insulin Delivery compendium is a comprehensive resource for clinical news and expert insights for this technology, which has revolutionized diabetes care.

Superior T1D Control Seen With HCL Systems vs SAP Therapy in Older Adults

May 15th 2022, 8:13pm


Type 1 diabetes (T1D) can be especially difficult to manage in older adults, so this new multinational review compared the safety and effectiveness of a hybrid closed-loop (HCL) system and sensor-augmented pump (SAP) therapy.

HCL Systems Convey Superior Glucose Outcomes vs Other Diabetes Technologies

May 11th 2022, 7:34pm


This new study among a patient population living with type 1 diabetes compared their outcomes according to their type of insulin pump therapy: sensor-augmented pump, predictive low-glucose suspend, and hybrid closed-loop (HCL).

Study Incorporates CGM Data for Guideline, Treatment Development

May 9th 2022, 5:53pm


A new study incorporated use of readings from continuous glucose monitors (CGMs) to establish reference sensor glucose ranges among healthy nondiabetic children aged 1 to 6 years.

SES-Related Insulin Pump Uptake Disparities Seen in 2 Canadian Provinces

May 4th 2022, 3:00pm


Using socioeconomic status (SES) as their primary exposure, investigators from McGill University, University of Manitoba, Institut National de Santé Publique du Québec, and Laval University investigated reasons behind insulin pump uptake disparities in the Canadian provinces of Manitoba and Québec.

Results of Omnipod 5 Type 2 Feasbility Study Presented at ATTD

May 3rd 2022, 3:45pm


Patients with type 2 diabetes who used the Omnipod 5 had lower A1C after 8 weeks. Those who had been using multiple daily injections achieved the greatest benefits in reduced hypoglycemia and reduced insulin use.

Real-Time CGM Can Help Shape Patient Education, Glycemic Index Measures in T2D

April 30th 2022, 7:02pm


Investigators from Malaysia utilized data from real-time continuous glucose monitoring (CGM) among study participants who were considered overweight or obese to evaluate their risk of type 2 diabetes (T2D) associated with a rice-based meal and its impact on postprandial hyperglycemia.

CLS Use Proved Superior at Reducing Adverse Outcomes in T1D vs Control Therapies

April 27th 2022, 10:07pm


This systematic review and meta-analysis used a literature search to gather data from long-term randomized controlled trials on the effectiveness of closed-loop insulin systems (CLS) among nonpregnant patients with type 1 diabetes (T1D).

Use of CSII Linked to Lower Rates of DEB Among Children With T1D

April 23rd 2022, 4:38pm


This new study investigated and compared the incidence of disordered eating behavior (DEB) among 2 cohorts of patients with type 1 diabetes (T1D) treated with continuous-subcutaneous insulin infusion (CSII) or a basal-bolus regimen.

Model Algorithm Demonstrates Effectiveness for T1D Control During Pregnancy

April 19th 2022, 7:23pm


Investigators fashioned a zone-model predictive controller to evaluate adjustment of closed-loop glycemic control during pregnancy, as both glycemic control and insulin adjustment continually change throughout gestation.

Experts Explore the Potential of Wearable Tech in T1D Management

April 15th 2022, 1:14pm


This new literature review explored the potential to enhance management for type 1 diabetes (T1D) through the adoption of physiological parameters measured by wearable and sensor-enabled health-related technology.